CV Sciences (CVSI) Gross Margin (2013 - 2026)

CV Sciences (CVSI) reported Gross Margin of 48.89% for Q1 2026, up 291.0% on a YoY basis from 12.5% in Q1 2025, and down 3.25% sequentially from 50.53% in Q4 2025.

CV Sciences (CVSI) Gross Margin (2013 - 2026) Analysis & Trends

CV Sciences (CVSI) has 14 years of Gross Margin data on file, last reported at 48.89% in Q1 2026.

  • For the quarter ending Q1 2026, Gross Margin rose 291.0% year-over-year to 48.89%; the trailing twelve-month figure through Mar 2026 stood at 49.75% (up 420.0% YoY), and the FY2025 full-year result was 48.97%, up 333.0% from the prior year.
  • Gross Margin declined to 48.89% in Q1 2026, from 50.53% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 50.94% in Q2 2025 to a low of 26.0% in Q1 2022.
  • A 5-year average of 43.72% and a median of 45.83% in 2023 frame the typical range for Gross Margin.
  • Across the five-year window, Gross Margin slumped 2268 bps in 2022 and soared 1697 bps in 2023, its largest moves.
  • Tracing CVSI's Gross Margin over 5 years: stood at 40.37% in 2022, then grew by 14 bps to 45.83% in 2023, then fell by 6 bps to 43.18% in 2024, then increased by 17 bps to 50.53% in 2025, then dropped by 3 bps to 48.89% in 2026.
  • Business Quant data shows CVSI's Gross Margin at 48.89% in Q1 2026, 50.53% in Q4 2025, and 48.5% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 49.52%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 71.66%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 62.93%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 82.93%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 32.97%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 98.31%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.26%
10 CV Sciences 3.74 Mn 3.43 Mn 1.56 Mn 48.89%

Historic Data

Download Data
DateValue
Mar 31, 2026 48.89%
Dec 31, 2025 50.53%
Sep 30, 2025 48.50%
Jun 30, 2025 50.94%
Mar 31, 2025 45.98%
Dec 31, 2024 43.18%
Sep 30, 2024 46.00%
Jun 30, 2024 47.04%
Mar 31, 2024 46.30%
Dec 31, 2023 45.83%
Sep 30, 2023 45.07%
Jun 30, 2023 43.32%
Mar 31, 2023 42.96%
Dec 31, 2022 40.37%
Sep 30, 2022 41.64%
Jun 30, 2022 30.69%
Mar 31, 2022 26.00%
Dec 31, 2021 32.40%
Sep 30, 2021 46.17%
Jun 30, 2021 44.66%